Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-methylfolate Supplementation to OROS-Methylphenidate in Adult ADHD
NCT01853280Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- May 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 5-MTHF in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Started May 2014; status: completed.
02
Drugs
5-MTHF
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01853280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01853280.